Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2021-04-29 | "Paul Clancy, age 59... Upon the recommendation of the Corporate Governance and Nominating Committee... Paul Clancy is currently a Class I director..." and "The Audit and Finance Committee is comprised of Paul Clancy..." and "Paul Clancy did not join our Board of Directors until March 18, 2021 and thus received no compensation in the one-year period ended December 31, 2020." |
| 2022-04-29 | Paul Clancy has more than 30 years of experience in financial management... Age: 60 ... Board Committees: Audit and Finance (Chair); Corporate Governance & Nominating ... Total ($) 426,835 |
| 2023-04-26 | Paul Clancy ... Current class of director: III ... Independent Director ... Board Committees: • Audit and Finance (Chair) • Corporate Governance and Nominating ... |
| 2024-04-25 | Paul Clancy* ... 62 ... Class III ... Former Executive Vice President and Chief Financial Officer of Alexion Pharmaceuticals, Inc. ... AGE: 62 INDEPENDENT DIRECTOR (CLASS III) SINCE: 2021 COMMITTEES Audit and Finance (Chair) Corporate Governance and Nominating ... Total ($) 417,749 |
Source material: SEC submissions metadata and DEF 14A proxy filings from EDGAR. Last updated: 2026-05-06